Results 121 to 130 of about 2,984 (199)

Optimizing CMV prevention after allogenic hematopoietic stem cell transplantation: using CMV-specific cellular immunity to guide letermovir prophylaxis. [PDF]

Blood Sci
Zhen S, Chen X, Feng S.
europepmc   +1 more source

Management of CMV Pneumonia, DAH, and BOS Following HSCT in a Child with β-Thalassemia: A Case Report. [PDF]

J Inflamm Res
Li L, Chen T, Feng Y, Kong P, Zhang X.
europepmc   +1 more source

Secondary Prophylaxis With Bioequivalent Generic Letermovir in Haploidentical Hematopoietic Stem Cell Transplantation: A Case Report. [PDF]

Cureus
Baheti A, Bharat S.
europepmc   +1 more source

Pretransplant CMV-IgG Titers and DNAemia Are Associated With CMV Infections Post Allogeneic Hematopoietic Cell Transplant With or Without Letermovir. [PDF]

Open Forum Infect Dis
Royston L, Zou M, Simonetta F, Schibler M, Yerly S, Pradier A, Giannotti F, Mamez AC, Morin S, Van Delden C, Kaiser L, Chalandon Y, Masouridi-Levrat S, Neofytos D.   +13 more
europepmc   +1 more source

Letermovir in paediatric HSCT recipients

Journal of Antimicrobial Chemotherapy, 2019
Volker, Strenger, Daniela, Sperl, Klaus, Kubesch, Josef, Donnerer, Wolfgang, Schwinger, Klara, Zach, Herwig, Lackner, Martin, Benesch   +7 more
openaire   +2 more sources

Early CMV DNAemia during letermovir prophylaxis predicts lower risk of late CMV infection and is associated with enhanced T-cell immunity after alloHSCT. [PDF]

Sci Rep
Duplessix T, Baermann BN, Hölscher AS, Tometten I, Schulz F, Munder S, Le DB, Jäger P, Nachtkamp K, Dietrich S, Timm J, Kobbe G, Lübke N.   +12 more
europepmc   +1 more source

Efficacy and safety of letermovir for cytomegalovirus prophylaxis in thoracic organ transplantation: a systematic review and meta-analysis. [PDF]

BMC Infect Dis
Aldalati AY, Hussein AM, Aldalati K, Hammadeh BM, Alrabadi B, Al-Dabagh A, Albliwi M, Abuassi M, Rawashdeh B.   +8 more
europepmc   +1 more source

Real-World Use of Letermovir and Maribavir for CMV Prophylaxis and Treatment in Solid Organ Transplant Recipients: Clinical Outcomes and Resistance Patterns From a Dual-Center Cohort. [PDF]

Pharmacotherapy
Xu MT, Wright A, Mah A, Matic N, Lowe C, Hong C, Belga S, Tsai WP.   +7 more
europepmc   +1 more source

Current and Future Strategies for the Prevention and Treatment of Cytomegalovirus Infections in Transplantation. [PDF]

Clin Infect Dis
Heldman MR, Boeckh MJ, Limaye AP.
europepmc   +1 more source

Integrated Life Cycle Assessment Guides Sustainability in Synthesis: Antiviral Letermovir as a Case Study. [PDF]

J Am Chem Soc
Folkerts S, Hoepfner MG, Guillén-Gosálbez G, Pérez-Ramírez J, Carreira EM.   +4 more
europepmc   +1 more source